Ronald Berger

2013

In 2013, Ronald Berger earned a total compensation of $110.5K as Interim Chief Financial Officer at Cytosorbents.

Compensation breakdown

Bonus$200
Option Awards$9,800
Other$100,526
Total$110,526

Berger received $100.5K in other compensation, accounting for 91% of the total pay in 2013.

Berger also received $200 in bonus and $9.8K in option awards.

Rankings

In 2013, Ronald Berger's compensation ranked 12,039th out of 12,286 executives tracked by ExecPay. In other words, Berger earned more than 2.0% of executives.

ClassificationRankingPercentile
All
12,039
out of 12,286
2nd
Division
Manufacturing
4,519
out of 4,612
2nd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
671
out of 681
2nd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
411
out of 420
2nd
Industry
Surgical and Medical Instruments and Apparatus
256
out of 263
3rd
Source: SEC filing on April 22, 2015.

Berger's colleagues

We found four more compensation records of executives who worked with Ronald Berger at Cytosorbents in 2013.

2013

Phillip Chan

Cytosorbents

Chief Executive Officer

2013

Vincent Capponi

Cytosorbents

Chief Operating Officer

2013

Kathleen Bloch

Cytosorbents

Chief Financial Officer

2013

Robert Bartlett

Cytosorbents

Chief Medical Officer

You may also like